options a bargain, page-25

Justing thinking....researching ECQ will be a huge effort considering this field is not my strong point...definitely agree there is merit to biotech bubble thesis....the hard thing is ascrbing a fundamental value to the intellectual property or the potential intellectual property that will drive the technicals....one could just trade on price volume...the question is how does ECQ compare to the other 2200+ companies listed on the ASX in terms of pobabilities of price appreciation...just thinking...